Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor Measurement

Table 1

Patient characteristics.

Number of patients treated	12
Median age (range) years	32 (18–72)
Median BMI (range)	30.18 (18.77–48.28)
Gender
Female	7 (58%)
Male	5 (42%)
Race
African American	1 (8%)
Asian	1 (8%)
Caucasian	7 (58%)
Hispanic	2 (17%)
Unknown	1 (8%)
Performance status (ECOG) at cycle 1, day 1^a
0	4 (33%)
1	5 (42%)
2	2 (17%)
Stage at consent
IVA	6 (50%)
IVB	6 (50%)
Grade at consent^b
1	1 (8%)
2	0 (0%)
3	2 (17%)
4	7 (58%)

^aMissing for one patient at C1D1 (at screening ECOG 0). At screening, ECOG 0/1 was 4/8. ^bMissing for two patients.